An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, 6 months open label safety extension study for all patients who are
willing and eligible to continue from the pivotal, double-blind S308.3.001 trial